Invitation to Cosmo's GI Genius™ Q&A session for investors, analysts and journalist PR Newswire DUBLIN, April 28, 2021 DUBLIN, April 28, 2021 /PRNewswire/ -- Cosmo Pharmaceuticals N.V. (SIX:...
Cosmo announces FDA approval of GI Genius™ intelligent endoscopy module, its revolutionary Artificial Intelligence device for lesion detection during colonoscopy PR Newswire DUBLIN, April 12...
Cosmo Full-Year Report 2020: Cosmo returns to operating profit PR Newswire DUBLIN, March 26, 2021 DUBLIN, March 26, 2021 /PRNewswire/ -- Cosmo Pharmaceuticals N.V. (SIX: COPN) reports Full-Year...
Invitation to Cosmo's 2020 results / 2021 outlook presentation conference call on 26 March 2021 PR Newswire DUBLIN, March 19, 2021 DUBLIN, March 19, 2021 /PRNewswire/ -- Cosmo Pharmaceuticals NV...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 126.9 | 126.9 | 126.9 | 179 | 126.9 | DE |
4 | 0 | 0 | 126.9 | 126.9 | 126.9 | 334 | 126.9 | DE |
12 | 0 | 0 | 126.9 | 126.9 | 126.9 | 449 | 126.9 | DE |
26 | 0 | 0 | 126.9 | 126.9 | 126.9 | 541 | 126.9 | DE |
52 | 0 | 0 | 126.9 | 126.9 | 126.9 | 819 | 126.9 | DE |
156 | 0 | 0 | 126.9 | 126.9 | 126.9 | 1114 | 126.9 | DE |
260 | 0 | 0 | 126.9 | 126.9 | 126.9 | 921 | 126.9 | DE |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales